Valerio Therapeutics Société anonyme (LON:0NWK)
London flag London · Delayed Price · Currency is GBP · Price in EUR
0.1580
0.00 (0.00%)
At close: Feb 12, 2026

LON:0NWK Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
651022143247
Market Cap Growth
550.98%-56.71%59.06%-57.13%-30.57%69.66%
Enterprise Value
83171932136
Last Close Price
0.140.060.150.140.460.65
PE Ratio
-----47.76
PS Ratio
41.266.4414.1210.849.4829.29
PB Ratio
-8.94-1.401.720.701.171.79
P/TBV Ratio
---3.712.594.74
EV/Sales Ratio
52.0011.5812.332.506.0622.40
Debt / Equity Ratio
-2.70-2.000.740.460.300.22
Debt / EBITDA Ratio
3.87-----
Net Debt / Equity Ratio
-2.39-1.860.28-0.20-0.24-0.28
Net Debt / EBITDA Ratio
3.66-3.95-0.220.261.441.08
Net Debt / FCF Ratio
-2.10-1.20-0.240.450.911.72
Asset Turnover
0.070.070.050.030.080.04
Quick Ratio
0.350.251.052.784.063.77
Current Ratio
0.350.251.172.884.273.83
Return on Equity (ROE)
--731.83%-109.75%-70.86%-19.16%4.71%
Return on Assets (ROA)
-13.78%-38.74%-30.39%-22.25%-7.01%-11.61%
Return on Invested Capital (ROIC)
-46.75%-126.32%-103.53%-79.95%-24.40%-22.57%
Return on Capital Employed (ROCE)
667.60%4041.70%-78.90%-47.60%-12.10%-19.30%
Earnings Yield
-17.46%-207.23%-80.02%-125.10%-15.41%2.09%
FCF Yield
-12.73%-110.66%-69.13%-63.51%-22.61%-9.22%
Buyback Yield / Dilution
3.99%-13.81%-27.86%-19.88%-17.03%-23.61%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.